These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10472481)

  • 1. Emerging nosocomial infections and antimicrobial resistance.
    Gerberding JL; McGowan JE; Tenover FC
    Curr Clin Top Infect Dis; 1999; 19():83-98. PubMed ID: 10472481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
    Kuwahara K; Hanaki H; Hiramatsu K
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):182-5. PubMed ID: 10088368
    [No Abstract]   [Full Text] [Related]  

  • 3. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P; Naas T; Fortineau N; Poirel L
    Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fighting MRSA in hospitals: time to restrict the broad use of specific antimicrobial classes?
    Monnet DL; MacKenzie FM; Skov R; Jensen ET; Gould IM; Frimodt-Møller N
    J Hosp Infect; 2005 Nov; 61(3):267-8. PubMed ID: 16009460
    [No Abstract]   [Full Text] [Related]  

  • 5. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
    Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
    Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcal infections: a historical perspective.
    Shinefield HR; Ruff NL
    Infect Dis Clin North Am; 2009 Mar; 23(1):1-15. PubMed ID: 19135913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bad bugs. What you need to know about VRE/MRSA.
    Lejeune JR; Berkowitz DM
    JEMS; 2000 Dec; 25(12):56-61; quiz 62. PubMed ID: 11138384
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotic resistance. Epidemiology of resistance in intensive therapy units (ITUs).
    Fraise AP
    J Med Microbiol; 1997 Jun; 46(6):447-9. PubMed ID: 9379471
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic resistance. Nosocomial gram-positive infection.
    Cookson B; Morrison D; Marples R
    J Med Microbiol; 1997 Jun; 46(6):439-42. PubMed ID: 9379468
    [No Abstract]   [Full Text] [Related]  

  • 10. [Staphylococci and enterococci resistant to glycopeptides: the challenge of the year 2000?].
    Mainardi JL
    Pathol Biol (Paris); 1998 May; 46(5):289-90. PubMed ID: 9769886
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementing guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: how valid are international comparisons of success?
    Humphreys H
    J Hosp Infect; 2006 Feb; 62(2):133-5. PubMed ID: 16337032
    [No Abstract]   [Full Text] [Related]  

  • 12. For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?
    Farr BM
    Clin Infect Dis; 2004 Apr; 38(8):1116-8. PubMed ID: 15095216
    [No Abstract]   [Full Text] [Related]  

  • 13. Computer keyboards and faucet handles as reservoirs of nosocomial pathogens in the intensive care unit.
    Bures S; Fishbain JT; Uyehara CF; Parker JM; Berg BW
    Am J Infect Control; 2000 Dec; 28(6):465-71. PubMed ID: 11114617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Bugged' phones.
    Desikan P; Trivedi S; Jain A
    Natl Med J India; 2003; 16(5):285. PubMed ID: 14680289
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical correlates of vancomycin-resistant enterococci/meticillin-resistant Staphylococcus aureus co-colonization and co-infection in Singapore.
    Kurup A; Wong YY; Tan KY; Low JG
    J Hosp Infect; 2008 Nov; 70(3):291-2. PubMed ID: 18804897
    [No Abstract]   [Full Text] [Related]  

  • 16. [Emergence of gram-positive organisms: causes, clinical significance and possibilities of control].
    García-Rodríguez JA; García Sánchez E
    Rev Clin Esp; 1997 Sep; 197 Suppl 2():3-11. PubMed ID: 9441320
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. Introduction.
    Lode H
    Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():1-2. PubMed ID: 18318873
    [No Abstract]   [Full Text] [Related]  

  • 18. The bacteria fight back.
    Taubes G
    Science; 2008 Jul; 321(5887):356-61. PubMed ID: 18635788
    [No Abstract]   [Full Text] [Related]  

  • 19. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
    Hota B
    Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbial disease trends and acquired antibiotic resistance: Part 2: Evolving microbial pathogens--antibiotic-resistant Staphylococcus aureus.
    Molinari JA
    Compend Contin Educ Dent; 1997 Apr; 18(4):320-2. PubMed ID: 9452540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.